Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Dual dopamine D2/D3 receptor ligand described with antipsychotic efficacy

Sep. 12, 2006

University of Arizona presents a novel bifunctional opioid agonist/NK-1 antagonist

Sep. 12, 2006

Scripps patent discloses novel transthyretin amyloid inhibitors for amyloidosis

Sep. 8, 2006

Laquinimod reduces rate of inflammatory disease activity in MS patients

Sep. 8, 2006

Abuse resistant drug ELI-216 studied in phase II

Sep. 8, 2006

GSK reports on a novel candidate for histamine H3 antagonism in AD

Sep. 8, 2006

LX-6171 for cognitive disorders begins phase I study

Sep. 8, 2006

NDA for CIP-Tramadol ER accepted for review

Sep. 7, 2006

Coprimary endpoints not met in phase III trial of LidoPAIN

Sep. 7, 2006

Santhera and Juvantia collaborate on fipamezole for Parkinson's dyskinesia

Sep. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...